Skip to main content
Home News Page 2

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://otc.duke.edu/wp-content/uploads/2025/01/vividion-tavros-acquisition.png

Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform

Tavros Therapeutics was co-founded by Eoin McDonnell, graduate of the Duke University Molecular Cancer Biology PhD Program, and Associate Professor Kris Wood (Pharmacology and Cancer Biology, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/humacyte-logo-new.png

Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

Humacyte is a Duke University start-up out of the lab of Dr. Laura Niklason (formerly Anesthesiology, SOM), co-founded with Drs. Juliana Blum and Shannon Dahl.

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/TUSW-Dec-2024-featured-image-v3.jpeg

Duke, UNC, and NC State academics get crash course in building startups

Faculty and students with promising IP developed at Triangle universities were invited to workshop their ideas with the help of serial entrepreneurs.

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/TVNZ-featured-image.png

How old are you, really? Biological aging tech from Duke inventors spotlighted on TV

Professors Terrie Moffitt and Avshalom Caspi (Psychology & Neuroscience, Trinity) are leading experts in biological aging and have invented a test that is now a commercial product.

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/bigner-featured-image.png

Seeds of Hope – Duke Magazine

Dr. Darell Bigner journeys from the farm to the heights of neuro-oncology and back again

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/greenlight-logo-above-pattern-health-logo.png

Greenlight Health Data Solutions and Pattern Health Merge to Expand Healthcare, Life Sciences and Insurance Solutions

Pattern Health has licensed numerous technologies from Duke inventors, primarily clinical trial management software and supporting materials from the Duke University School of Medicine.

Read More

https://otc.duke.edu/wp-content/uploads/2023/10/BMI_OrganBank_Logo.jpg

NSF-Piedmont Triad Regenerative Medicine Engine (PTRME) Awards $2.5 Million in Grants to Drive Economic Growth

BMI OrganBank licensed perfusion tech from the Duke Ex-Vivo Organ Lab, led by Drs. Andrew S. Barbas and Matthew Hartwig (Surgery, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/11/1.-Invented-at-Duke-2024-featured-image.jpeg

Invented at Duke 2024 showcases the past and present of innovation at Duke, promising a bright future

A special Centennial edition of Invented at Duke featured inventors and innovations from the past, present, and future of Duke.

Read More

https://otc.duke.edu/wp-content/uploads/2023/10/BMI_OrganBank_Logo.jpg

BMI OrganBank Secures $3.5 Million NIH Grant to Advance Innovative Kidney Preservation Technology Towards Clinical Trials

BMI OrganBank licensed perfusion tech from the Duke Ex-Vivo Organ Lab, led by Drs. Andrew S. Barbas and Matthew Hartwig (Surgery, SOM).

Read More